Eterna Therapeutics Inc
ERNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.32M
Close$
$5.53
31% downside
Current Fair Value
31% downsideOvervalued by 31% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.32 Million |
|---|---|
| Enterprise Value | $-5,463,709.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-56 |
| Beta | 1.89 |
| Outstanding Shares | 792,000 |
Return
| Return on Equity | -166.13% |
|---|---|
| Return on Assets | -108.08% |
| Return on Invested Capital | -131.87% |
Valuation & Multiples
| P/E Ratio | -0.74 |
|---|---|
| PEG | 2.24 |
| Price to Sales | - |
| Price to Book Ratio | 1.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.58 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.07 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-1.95
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-3.30
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 18.05%▲ 9.76% |
|---|---|
| Total Invested | $711,400▲ 13.44% |
| Investors Holding | 19▲ 5.00% |
ESG Score
No data
About Eterna Therapeutics Inc
2,018 employees